Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors
Sachithra Thazhathuveedu Sudevan, T. M. Rangarajan, Abdullah G. Al‐Sehemi, Aathira Sujathan Nair, Vishal Payyalot Koyiparambath, Bijo Mathew
Abstract
The conceptual layout of monoamine oxidase (MAO) inhibitors has been modified to explore their potential biological application in the case of neurological disorders for the time being. The current review article is an effort to display the summation of innovative conceptual prospects of MAO inhibitors and their intriguing chemistry and bioactivity. Based on this scenario, we emphasize the pivotal role of the benzyloxy moiety attached to scaffolds like oxadiazolones, indolalkylamines, safinamide, caffeine, benzofurans, α-tetralones, β-nitrostyrene, benzoquinones, coumarins, indoles, chromones, and chromanone analogs, while acting as an MAO inhibitor.